Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Hold
600
0.03% 60
2026
Q1
$211K Buy
+600
New +$214K 0.03% 62
2023
Q1
Sell
-770
Closed -$202K 52
2022
Q4
$202K Buy
+770
New +$206K 0.03% 54
2022
Q3
Sell
-830
Closed -$202K 56
2022
Q2
$202K Buy
+830
New +$203K 0.03% 56

Other funds holding AMGN

Cortland Associates's AMGN Position: Q2 2026 in Review

Cortland Associates held its Amgen (AMGN) position steady in Q2 2026 at 600 shares worth $217K. The position accounts for 0.03% of the portfolio, ranked #60.

Cortland Associates first reported a position in AMGN in Q2 2022 and has held it in 4 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cortland Associates held 600 shares of Amgen worth $217K as of Q2 2026.
  • Cortland Associates left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.03% of Cortland Associates's portfolio in Q2 2026, its #60 holding.
  • Cortland Associates first reported a position in Amgen in Q2 2022 and has held it in 4 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cortland Associates's 13F filing for Q2 2026, filed 28 Jul 2026.